SynthesisAnnals of medicine2025

Ezetimibe and the risk of new-onset type 2 diabetes: a systematic review and meta-analysis.

Areej S Albawa'neh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.